Allogeneic Adipose Tissue Extract in Wound Treatment and Scar Maturation

This study will evaluate the effect of an allogeneic adipose tissue extract on wound healing and scar maturation. Thirty adult patients scheduled for skin graft surgery will be enrolled. Each patient will have two skin graft donor sites harvested. One skin graft donor site wound will be treated topically with the adipose tissue extract, applied immediately after harvesting and reapplied on Day 3, while the other skin graft donor site wound will receive standard care. The main outcome is the time to complete epithelialization of the wound, as confirmed by investigators and independent reviewers. Secondary measures include wound characteristics, scar formation and scar quality, and monitoring of adverse events, such as wound deterioration.

NCT Number	NCT07372404
Lead Sponsor	Linio Biotech Oy Collaborators: Hospital Nova, Central Finland
Conditions	Wound Healing
Enrollment	30 participants
Start Date	2023-04-11
Primary Completion	2026-06-24 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-25